Virtual HIV pre-exposure prophylaxis outpatient service in the era of COVID-19

Int J STD AIDS. 2021 Jan;32(1):100-103. doi: 10.1177/0956462420961951. Epub 2020 Oct 13.

Abstract

In the midst of the COVID-19 pandemic, health care providers have had to rapidly change how they deliver care to patients. We discuss how we are delivering a virtual HIV pre-exposure prophylaxis (PrEP) service during this time; challenges faced; challenges expected and goals for the coming months.

Keywords: Human immunodeficiency virus; antiretroviral therapy; prevention.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Ambulatory Care*
  • Anti-HIV Agents / administration & dosage*
  • COVID-19 / epidemiology*
  • COVID-19 / virology
  • Drug Therapy, Combination
  • Emtricitabine / administration & dosage*
  • Female
  • HIV Infections / prevention & control*
  • Humans
  • Ireland / epidemiology
  • Male
  • Middle Aged
  • Pandemics
  • Pre-Exposure Prophylaxis*
  • SARS-CoV-2 / isolation & purification
  • Tenofovir / administration & dosage*

Substances

  • Anti-HIV Agents
  • Tenofovir
  • Emtricitabine